Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fareed

Showing results (301-310 of 384) with videos related to

Pageof 39
Sort By:
Seminars in Thrombosis and Hemostasis|October 1, 1984
Diagnostic efficacy of a simple radioimmunoassay test for fibrinogen/fibrin fragments containing the B beta 15-42 sequenceJ M Walenga, J Fareed, G Mariani, et al.
International Angiology : a Journal of the International Union of Angiology|December 14, 2006
Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial)S Haas, H G Breyer, H P Bacher, et al.
Expert Opinion on Emerging Drugs|July 2, 2005
Emerging anticoagulant and thrombolytic drugsO Iqbal, S Aziz, D A Hoppensteadt, et al.
International Angiology : a Journal of the International Union of Angiology|May 29, 2008
Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?J Fareed, O Iqbal, J Cunanan, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 24, 2001
The effect of a novel glycoprotein IIb/IIIa antagonist, SR 121566A, on platelet aggregation and activation in rhesus monkeysM K Orcullo Santillan, J Herring, D A Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 8, 2011
Defibrotide blunts the prothrombotic effect of thalidomide on endothelial cellsC L Echart, S Somaini, M Distaso, et al.
Journal of Vascular Surgery|November 1, 1995
Modifications of plasma levels of tissue factor pathway inhibitor and endothelin-1 induced by a reverse Trendelenburg position: influence of elastic compression--preliminary resultsJ I Arcelus, J A Caprini, K N Hoffman, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Thrombogenesis in myocardial infarction and related syndromes: the role of molecular markers in diagnosis and managementJ Fareed, D A Hoppensteadt, F Leya, et al.
Comparative Biochemistry and Physiology. Part A, Physiology|July 1, 1995
A comparative study on the mechanism of the anticoagulant action of mollusc and mammalian heparinsJ F Paiva, E A Santos, W Jeske, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
Evaluation of hematologic alterations associated with daily administration of low molecular weight heparin (Mono-Embolex) for a 12-week periodB Lojewski, P Bacher, O Iqbal, et al.
Pageof 39

Showing results (301-310 of 384) with videos related to

Sort By:
Pageof 39
Seminars in Thrombosis and Hemostasis|October 1, 1984
Diagnostic efficacy of a simple radioimmunoassay test for fibrinogen/fibrin fragments containing the B beta 15-42 sequenceJ M Walenga, J Fareed, G Mariani, et al.
International Angiology : a Journal of the International Union of Angiology|December 14, 2006
Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial)S Haas, H G Breyer, H P Bacher, et al.
Expert Opinion on Emerging Drugs|July 2, 2005
Emerging anticoagulant and thrombolytic drugsO Iqbal, S Aziz, D A Hoppensteadt, et al.
International Angiology : a Journal of the International Union of Angiology|May 29, 2008
Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?J Fareed, O Iqbal, J Cunanan, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 24, 2001
The effect of a novel glycoprotein IIb/IIIa antagonist, SR 121566A, on platelet aggregation and activation in rhesus monkeysM K Orcullo Santillan, J Herring, D A Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 8, 2011
Defibrotide blunts the prothrombotic effect of thalidomide on endothelial cellsC L Echart, S Somaini, M Distaso, et al.
Journal of Vascular Surgery|November 1, 1995
Modifications of plasma levels of tissue factor pathway inhibitor and endothelin-1 induced by a reverse Trendelenburg position: influence of elastic compression--preliminary resultsJ I Arcelus, J A Caprini, K N Hoffman, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Thrombogenesis in myocardial infarction and related syndromes: the role of molecular markers in diagnosis and managementJ Fareed, D A Hoppensteadt, F Leya, et al.
Comparative Biochemistry and Physiology. Part A, Physiology|July 1, 1995
A comparative study on the mechanism of the anticoagulant action of mollusc and mammalian heparinsJ F Paiva, E A Santos, W Jeske, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
Evaluation of hematologic alterations associated with daily administration of low molecular weight heparin (Mono-Embolex) for a 12-week periodB Lojewski, P Bacher, O Iqbal, et al.
Pageof 39